Showing 35,583 results

Filters
Injectable & long-acting PrEP

Community Manifesto for HIV Long-Acting Injectable PrEP in Europe

Editor's pick
EATG
20 October 2023
Cardiovascular disease

EACS 2023: COVID-19 and cardiovascular disease Video

October 2023

EACS 2023 : Risque accru de maladie cardiovasculaire après le COVID-19, vendredi 20 Octobre 2023

October 2023

EACS 2023: Mayor riesgo de enfermedades cardiovasculares tras la COVID-19, viernes 20 de octubre de 2023

October 2023
Treatment simplification strategies

Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure

News
20 October 2023

EACS 2023: Higher risk of cardiovascular disease after COVID-19, Friday 20 October 2023

October 2023
Cardiovascular disease

COVID-19 raises the risk of cardiovascular disease in people with HIV

News
20 October 2023
Mental & emotional health problems

One in seven people at Amsterdam HIV clinic have symptoms of post-traumatic stress disorder

News
20 October 2023
Weight gain & lipodystrophy

Weight Loss or Gain Predictors Hard to Find in INSTI-to-PI Switch Trial

Editor's pick
NATAP
19 October 2023
Improving HIV care

Pharmacist-Driven ART Start Cuts 37 Day Off Time From HIV Diagnosis to Undetectable

Editor's pick
NATAP
19 October 2023
Injectable & long-acting PrEP

Gilead Sciences Announces New Clinical Trial in Europe to Assess Lenacapavir for HIV Prevention as Part of Landmark Purpose Program

Editor's pick
Gilead Sciences press release
19 October 2023
Bad science & bogus treatments

Beware of this dangerous advice! Colloidal silver cannot be used as an antibiotic or HIV medication

Editor's pick
Africa Check
19 October 2023
People with limited treatment options

Sunlenca Remains Active Against Drug-Resistant HIV

Editor's pick
POZ
19 October 2023
Exposure to HIV through medical procedures

‘I stopped counting how many friends died’: life after the contaminated blood scandal

Editor's pick
The Guardian
19 October 2023
HIV treatment

Real-World Evidence Reinforces Biktarvy® as a Long-Term Treatment Option With a High Barrier to Resistance for People With HIV and a Range of Comorbidities

Editor's pick
Gilead Sciences press release
19 October 2023
Migrants, refugees & displaced people

More than six out of ten migrant gay and bisexual men with HIV in France acquired it there

News
19 October 2023
News about aidsmap

Picture this – living with HIV

News
18 October 2023
Neurological & cognitive problems

HIV in the brain – does it correlate with neurocognitive symptoms?

News
18 October 2023

DoxyPEP: antibiotics to prevent STIs – HIV update, 17 October 2023

October 2023
People with limited treatment options

Intramuscular Administration of HIV Treatment Ibalizumab Compared With IV Infusion

Editor's pick
Monthly Prescribing Reference
17 October 2023
Hepatitis B

Hepatitis B Reactivation Risk Low in People With HIV Following Antiretroviral Switch

Editor's pick
Contagion Live
17 October 2023
Combatting stigma

Young HIV advocates stand up to fake news and stigma

Editor's pick
UNICEF
17 October 2023
Cancer

Only Half of MSM With HIV Getting Screened for Anal Cancer

Editor's pick
NATAP
17 October 2023
Quality of life

Each Added Comorbidity Cuts 4 Points Off QOL Index in US Women With HIV

Editor's pick
NATAP
17 October 2023